Caricamento...

Circulating N‐Linked Glycoprotein Side‐Chain Biomarker, Rosuvastatin Therapy, and Incident Cardiovascular Disease: An Analysis From the JUPITER Trial

BACKGROUND: GlycA, a novel protein glycan biomarker of N‐acetyl side chains of acute‐phase proteins, was recently associated with incident cardiovascular disease (CVD) in healthy women. Whether GlycA predicts CVD events in the setting of statin therapy in men and women without CVD but with evidence...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Am Heart Assoc
Autori principali: Akinkuolie, Akintunde O., Glynn, Robert J., Padmanabhan, Latha, Ridker, Paul M, Mora, Samia
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2016
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5015410/
https://ncbi.nlm.nih.gov/pubmed/27413042
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.116.003822
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !